Merkel Cell Carcinoma: A Bibliometric Analysis of the Top 100 Cited Publications

Dermatol Surg. 2022 Jan 1;48(1):22-27. doi: 10.1097/DSS.0000000000003251.

Abstract

Background: Bibliometric studies provide a quantitative statistical analysis of the published literature within a field of interest and allow for easy identification of the major contributing authors, funding sources, and publication trends within the field. To date, no bibliometric studies have been performed pertaining to Merkel cell carcinoma (MCC).

Objective: To identify the 100 most frequently cited articles in MCC through a bibliometric analysis of the literature.

Methods: Web of science was queried to determine the 100 most frequently cited MCC publications published between the years 1970 and 2019. Articles were listed by title, authors and their affiliated institutions, journal title and type, year of publication, country of origin, funding sources, and citation frequency.

Results: Among the 100 most frequently cited MCC publications, articles were cited between 67 and 589 times with a mean of 136.3 times. Articles were cited between 2.0 and 98.2 times per year since publication with a mean of 11.3 times per year. 67% of the articles were published in oncology journals; 33% and 10% of the articles in dermatology and surgery journals, respectively. The most represented journal was Cancer (12%). Paul Nghiem was the most frequently identified author (18%). 36% of the top 100 articles were published out of the University of Washington. The most frequent funding agency was the National Institutes of Health (77%).

Conclusion: Through this bibliometric analysis, researchers can easily identify key publications pertaining to MCC, which may in turn enhance their approach to understanding and practicing evidence-based medicine regarding MCC.

MeSH terms

  • Bibliometrics*
  • Carcinoma, Merkel Cell* / diagnosis
  • Carcinoma, Merkel Cell* / mortality
  • Carcinoma, Merkel Cell* / therapy
  • Evidence-Based Medicine / methods
  • Humans
  • Medical Oncology / methods
  • Skin Neoplasms* / diagnosis
  • Skin Neoplasms* / mortality
  • Skin Neoplasms* / therapy